Patents by Inventor GUILLAUME JACQUOT

GUILLAUME JACQUOT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TRANSFERRIN RECEPTOR-BINDING MOLECULES, CONJUGATES THEREOF AND THEIR USES
    Publication number: 20230414780
    Abstract: The invention relates to Variable Domain of Camelid Heavy Chain-only (VHH) molecules which bind TfR, conjugate compounds comprising such VHH molecules, and the uses thereof e.g., to transport molecules of pharmaceutical or diagnostic interest into cells and in organs, in pathological conditions including cancer.
    Type: Application
    Filed: June 22, 2023
    Publication date: December 28, 2023
    Inventors: ROMY COHEN, MARION DAVID, GUILLAUME JACQUOT, JAMAL TEMSAMANI, PASCALINE LECORCHE, MICHEL KHRESTCHATISKY
  • Activated neurotensin molecules and the uses thereof
    Patent number: 9821072
    Abstract: The present invention relates to activated neurotensin, pharmaceutical compositions comprising the same, and the uses thereof. The compounds and compositions of the invention may be used, e.g., to reduce body temperature, attenuate or halt seizures, reduce excitotoxicity, promote neuroprotection, reduce neuroinflammation and aberrant axonal sprouting or reduce pain.
    Type: Grant
    Filed: January 19, 2015
    Date of Patent: November 21, 2017
    Assignees: VECT-HORUS, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Guillaume Jacquot, Pascaline Lecorche, Michel Khrestchatisky
  • ACTIVATED NEUROTENSIN MOLECULES AND THE USES THEREOF
    Publication number: 20160354480
    Abstract: The present invention relates to activated neurotensin, pharmaceutical compositions comprising the same, and the uses thereof. The compounds and compositions of the invention may be used e.g., to reduce body temperature, attenuate or halt seizures, reduce excitotoxicity, promote neuroprotection, reduce neuroinflammation and aberrant axonal sprouting or reduce pain.
    Type: Application
    Filed: January 19, 2015
    Publication date: December 8, 2016
    Inventors: GUILLAUME JACQUOT, PASCALINE LECORCHE, MICHEL KHRESTCHATISKY